Major glycoprotein of the human erythrocyte membrane: Evidence for an amphipathic molecular structure1

https://doi.org/10.1016/S0003-9861(73)80019-0Get rights and content

Treatment of the major glycoprotein of the human red cell membrane [erythrocyte glycophorin (1)] with cyanogen bromide yields five fragments. On the basis of N-terminal analyses and tryptic overlaps three of these (designated C-1, C-2, and C-5) have been aligned as unique portions of a single polypeptide chain. C-5 and C-1 represent the N-terminal fragments, in that order, and the third, C-2, is the C-terminal fragment of the original polypeptide chain. Evidence is presented for a limited polypeptide microheterogeneity of the N-terminal portion of the molecule.

From the amino acid composition and carbohydrate content of the three fragments, C-5, C-1, and C-2, the molecule can be divided into three distinct regions or domains. These are (a) a receptor or carbohydrate containing N-terminal segment, (b) an internal hydrophobic domain of approximately 30 residues, and (c) a hydrophilic, proline-rich C-terminal portion. This unique molecular topography suggests an amphipathic model for the in situ orientation of this molecule in which the hydrophobic domain of the glycoprotein lies within the hydrophobic interior of the membrane. This model is supported by lactoperoxidase-catalyzed 125I-labeling experiments which suggest that the N-terminal (receptor) half of the molecule (fragment C-1) is exposed to the external environment of the cell, while the C-terminal segment (fragment C-2) extends into the interior of the cell.

References (36)

  • MorawieckiA.

    Biochim. Biophys. Acta

    (1964)
  • ZvilichovskyB. et al.

    Biochem. Biophys. Res. Commun.

    (1971)
  • KobylkaD. et al.

    Arch. Biochem. Biophys.

    (1972)
  • BenderW.W. et al.

    J. Mol. Biol.

    (1971)
  • SeamanG.V.F. et al.

    Biochem. Biophys. Res. Commun.

    (1971)
  • CarrawayK.L. et al.

    Biochim. Biophys. Acta

    (1971)
  • PhillipsD.R. et al.

    Biochem. Biophys. Res. Commun.

    (1971)
  • SegrestJ.P. et al.

    Biochem. Biophys. Res. Commun.

    (1971)
  • SingerS.J.
  • SegrestJ.P. et al.

    Biochem. Biophys. Res. Commun.

    (1972)
  • ShapiroA.L. et al.

    Biochem. Biophys. Res. Commun.

    (1967)
  • SegrestJ.P. et al.
  • HirsC.H.W.
  • DodgeJ.T. et al.

    Arch. Biochem. Biophys.

    (1963)
  • EngelmanD.M.

    J. Mol. Biol.

    (1971)
  • MarchesiV.T. et al.
  • WinzlerR.J.
  • WinzlerR.J. et al.

    Biochemistry

    (1967)
  • Cited by (165)

    • Novel zinc-binding site in the E2 domain regulates amyloid precursor-like protein 1 (APLP1) oligomerization

      2014, Journal of Biological Chemistry
      Citation Excerpt :

      Physiological concentrations of free zinc ions generally exceed copper ion concentrations by magnitudes (42, 43) due to the high number of copper chelation sites provided by proteins (44, 45). To validate the specificity of APLP1 oligomerization upon zinc exposure, we also tested APLP1-CFP in combination with glycophorin A-YFP (GypA), another single-pass transmembrane protein localized to the plasma membrane (46). Whereas a low basal level of FRET was observed due to random plasma membrane encounters between APLP1-CFP and GypA-YFP (Fig. 3E), the presence of zinc prompted a slight decrease in the nonspecific FRET signal indicative of fewer encounters of APLP1 and GypA (likely due to the increased APLP1-YFP oligomerization that lowered the number of freely diffusing APLP1 entities).

    View all citing articles on Scopus
    1

    Human Erythrocyte Glycophorin (1).

    2

    Present address: Baylor College of Medicine and the Methodist Hospital, Department of Internal Medicine, Houston, Texas 77025.

    View full text